Physician profile
Trevor Page
NPI 1477240034
$3,435.78
in general payments reported to CMS, 2019-2025
11 companies · $3,102 in 2025
The $3,102 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $124 · 2024: $210 · 2025: $3,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,576 · Travel and Lodging: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,575.92 |
| Travel and Lodging | $859.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,854.40 | 2023-2025 | Truelok, Tl-Hex Truelok Hexapod System, Galaxy Fixation System |
| Trimed, INC. | $824.12 | 2025 | |
| Bioventus LLC | $144.44 | 2025 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $135.80 | 2025 | Portfolio |
| Stryker Corporation | $125.55 | 2025 | Prostep |
| Amgen INC. | $123.12 | 2025 | Krystexxa |
| Medical Device Business Services, INC. | $111.82 | 2025 | Na |
| Depuy Synthes Sales INC. | $38.64 | 2024 | Motoband |
| Exactech, INC. | $26.93 | 2025 | |
| Treace Medical Concepts, INC. | $26.84 | 2024 | |
| Smith+Nephew, INC. | $24.12 | 2025 | Q-Fix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.